This map shows the geographic impact of N Fuchsberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Fuchsberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Fuchsberger more than expected).
This network shows the impact of papers produced by N Fuchsberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Fuchsberger. The network helps show where N Fuchsberger may publish in the future.
Co-authorship network of co-authors of N Fuchsberger
This figure shows the co-authorship network connecting the top 25 collaborators of N Fuchsberger.
A scholar is included among the top collaborators of N Fuchsberger based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with N Fuchsberger. N Fuchsberger is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Slavíková, Monika, Marilyn L. Slovak, Iveta Vančová, et al.. (2002). Vesicular stomatitis virus nucleocapsid protein production in cells treated with selected fast protein liquid chromatography fractions of tick salivary gland extracts.. PubMed. 46(2). 117–20.3 indexed citations
Kontseková, Eva, Peter Kabát, V. Hajnická, et al.. (1998). Therapy-induced antibodies to interferon-alpha 2a recognise its receptor-binding site.. PubMed. 42(5). 279–84.3 indexed citations
Hajnická, V., et al.. (1996). Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line.. PubMed. 40(4). 221–2.6 indexed citations
Fuchsberger, N, et al.. (1993). In vitro antiproliferative effect of interferon alpha in solid tumors: a potential predictive test.. PubMed. 40(5). 293–6.4 indexed citations
13.
Rajcáni, J, et al.. (1988). A simple novel procedure for preparation of herpes simplex virus subunit vaccine.. PubMed. 32(4). 317–28.3 indexed citations
14.
Borecký, L & N Fuchsberger. (1983). Interferon as therapeutic agent.. PubMed. 27(4). 359–70.4 indexed citations
15.
Fuchsberger, N & L Borecký. (1979). Production of human leukocyte interferon for clinical use under immunoelectrophoretic control.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(5-6). 795–800.1 indexed citations
16.
Fuchsberger, N & L Borecký. (1979). Decrease of sensitivity to cell-growth inhibitory effect of interferon in human embryo cells after infection with SV40.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(4). 344–7.1 indexed citations
17.
Fuchsberger, N & L Borecký. (1978). Quantitative immunoelectrophoresis of human interferon. A new approach to characterization of interferon preparations.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(3). 238–40.1 indexed citations
18.
Fuchsberger, N, et al.. (1976). Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(4). 326–33.1 indexed citations
19.
Styk, B, et al.. (1973). Contribution to the problem of purity of interferon preparations.. PubMed. 17(2). 163–6.
20.
Fuchsberger, N, et al.. (1972). Evaluation of the Czechoslovak double-stranded RNA preparation as inducer of interferon in model experiments.. PubMed. 16(6). 466–76.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.